Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1 * 28 or * 6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A)

BACKGROUND: Various polymorphisms have been detected in the UDP‐glucuronosyltransferase 1A (UGT1A) gene, and UGT1A1 *28 and UGT1A1 *6 have important effects on the pharmacokinetics of irinotecan and the risk of severe toxicities during irinotecan therapy. This study was conducted to determine the ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Minoru, Shimada, Midori, Kitazaki, Takeshi, Nagashima, Seiji, Hashiguchi, Kohji, Ebi, Noriyuki, Takayama, Koichi, Nakanishi, Yoichi, Semba, Hiroshi, Harada, Taishi, Seto, Takashi, Okamoto, Isamu, Ichinose, Yukito, Sugio, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217920/
https://www.ncbi.nlm.nih.gov/pubmed/27883280
http://dx.doi.org/10.1111/1759-7714.12407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217920/
https://www.ncbi.nlm.nih.gov/pubmed/27883280
http://dx.doi.org/10.1111/1759-7714.12407

Ejemplares similares